ELENA CRANDELL: Open Payments
NPI 1487329421 · CARSON CITY, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 20 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $121 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $183 |
| PFIZER INC. | 2 | $53 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $18 |
Products named: VRAYLAR, PREVNAR 20, CAPLYTA, BREZTRI, GARDASIL 9, GVOKE HYPOPEN, INJECTAFER, M-M-R II.
Industry payments across NV — which companies pay providers there.
